rxstat › Shortages › Budesonide

Budesonide shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Budesonide products are in shortage in Canada (3 of 17 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
3 of 17
In shortage since
Apr 14, 2022
Reports on file
44
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TARO-BUDESONIDE
0.125MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02494264 · since Apr 14, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-BUDESONIDE
0.25MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02494272 · since Jun 11, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-BUDESONIDE
0.5MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02494280 · since Apr 14, 2022, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-BUDESONIDE
0.125MG · SUSPENSION · TEVA CANADA LIMITED
DIN 02465949 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUDESONIDE
0.5MG · SUSPENSION · TEVA CANADA LIMITED
DIN 02465957 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
UCERIS
2MG · FOAM · BAUSCH HEALTH, CANADA INC.
DIN 02498057 · ended Aug 5, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-BUDESONIDE AQ
64MCG · SPRAY, METERED DOSE · MYLAN PHARMACEUTICALS ULC
DIN 02241003 · ended Apr 17, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-BUDESONIDE AQ
100MCG · SPRAY, METERED DOSE · MYLAN PHARMACEUTICALS ULC
DIN 02230648 · ended Apr 17, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-BUDESONIDE
0.25MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02494272 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Resolved
UCERIS
2MG · FOAM · BAUSCH HEALTH, CANADA INC.
DIN 02498057 · ended Jan 14, 2025 · Other (Please describe in comments)
Resolved
TEVA-BUDESONIDE
0.125MG · SUSPENSION · TEVA CANADA LIMITED
DIN 02465949 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUDESONIDE
0.125MG · SUSPENSION · TEVA CANADA LIMITED
DIN 02465949 · ended Oct 5, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 44 reports. All reports are on file with Health Canada.

What's happening

Budesonide is currently affected by 3 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Budesonide is classified under “OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS” (ATC R03BA).

Recent changes

Common questions

When will Budesonide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Budesonide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other drugs for obstructive airway diseases, inhalants)

Partial shortageFluticasone Propionate1 of 15 reported products affected · est. return Jul 3, 2026Partial shortageMometasone Furoate3 of 15 reported products affected · est. return Aug 7, 2026Partial shortageTiotropium1 of 2 reported products affectedNo current shortageFluticasone Furoate

All other drugs for obstructive airway diseases, inhalants shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.